Replies to post #11940 on Momenta Pharmaceuticals, Inc. (MNTA)

[jbog]

Opinion: Mnta does have a technical advantage. I do believe so otherwise why bother.

Are you sure? Or was it that MIT had the technical advantage that left its doors with the founders of Momenta.

Fact: Ampha's a-enox approval is not proof of ability but a quirk of the american legal system.At the time there was another competitor I can't remember (a partner of Teva I believe) but they did not choose to go the same way as Ampha to get approval.

The legal reference you make has to do with proving that their substance was correct. It had nothing what-so-ever to do with them coming up with the product in the 1st place.

Momenta/Baxter won't amount to anything in the bio space. IMO